Benitec Wins US Patent Allowance, Says Separate IP Re-exam Likely to Extend into Late 2010 | GenomeWeb

Australian expressed RNAi shop Benitec this week announced that it received a notice of allowance from the US Patent and Trademark Office for a patent application covering the use of multiple-promoter expression cassettes for simultaneous delivery of RNAi.

Separately last week, the company provided an update on its efforts to overcome rejections to its core US patent, stating that the USPTO won’t likely decide on a company appeal until the third quarter of next year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.